Does a short course of etanercept influence disease progression and radiographic changes in patients suspected of non-radiographic axial spondyloarthritis? Three -years follow- up of a placebo-controlled trial.

T Rusman, Mac van der Weijden,M T Nurmohamed,C J van Denderen, Rbm Landewé,P M Bet, Cma van der Bijl,C J van der Laken,I E van der Horst-Bruinsma

Scandinavian journal of rheumatology（2023）

引用 0|浏览14

暂无评分

摘要

A short course of etanercept in patients with suspected nr-axSpA did not affect disease activity, the chance of biological treatment, or radiographic progression after 3 years of follow-up.

查看译文

关键词

Ankylosing Spondylitis,Treatment Recommendations

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要